All products / DC10820
Roquinimex(Linomide)
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $350 USDRequest a quote / confirm availability → |
| 250 mg | $600 USDRequest a quote / confirm availability → |
| 1 g | $1,350 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
Roquinimex (Linomide; PNU212616; ABR212616) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.IC50 value:Target: TNF alphaProphylactic administration of DSS-treated mice with roquinimex significantly reduced clinical signs of colitis, MDS and the CH-reduction. Moreover, in roquinimex treated animals, the MPO activity was significantly reduced by more than 50% compared to DSS control mice. Notably, therapeutic administration of roquinimex in DSS-treated mice also significantly inhibited the MDS, CH-reduction and MPO activity [2]. Linomide, a synthetic immunomodulator, at concentrations effective in vivo reduces the number of MBP-reactive TNF-alpha and increases MBP-reactive IL-10 and TGF-beta mRNA expressing MNC from MS patients' blood when analysed in vitro. Compared to dexamethasone, Linomide up-regulated levels of blood MNC expressing mRNA of TGF-beta after culture in presence of MBP [3].
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC10820 |
|---|---|
| Product name | Roquinimex(Linomide) |
| CAS | 84088-42-6 |
| Molecular formula | C18H16N2O3 |
| Molecular weight | 308.33124 |
| Purity | >98% |
| SMILES | CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Roquinimex(Linomide) (DC10820)